BE1014089A4 - Nouvelles metalloproteases possedant des domaines thrombospondine et compositions d'acides nucleiques les codant. - Google Patents
Nouvelles metalloproteases possedant des domaines thrombospondine et compositions d'acides nucleiques les codant. Download PDFInfo
- Publication number
- BE1014089A4 BE1014089A4 BE2001/0104A BE200100104A BE1014089A4 BE 1014089 A4 BE1014089 A4 BE 1014089A4 BE 2001/0104 A BE2001/0104 A BE 2001/0104A BE 200100104 A BE200100104 A BE 200100104A BE 1014089 A4 BE1014089 A4 BE 1014089A4
- Authority
- BE
- Belgium
- Prior art keywords
- nucleic acid
- mpts
- activity
- metalloprotease
- antagonist
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6489—Metalloendopeptidases (3.4.24)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Physical Education & Sports Medicine (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Immunology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US18415200P | 2000-02-18 | 2000-02-18 |
Publications (1)
Publication Number | Publication Date |
---|---|
BE1014089A4 true BE1014089A4 (fr) | 2003-04-01 |
Family
ID=22675774
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BE2001/0104A BE1014089A4 (fr) | 2000-02-18 | 2001-02-15 | Nouvelles metalloproteases possedant des domaines thrombospondine et compositions d'acides nucleiques les codant. |
Country Status (4)
Country | Link |
---|---|
BE (1) | BE1014089A4 (nl) |
CA (1) | CA2332533A1 (nl) |
IE (1) | IE20010121A1 (nl) |
NL (2) | NL1017393C2 (nl) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999005291A2 (en) * | 1997-07-25 | 1999-02-04 | Du Pont Pharmaceuticals Company | Aggrecan degrading metallo proteases |
WO2001042468A1 (en) * | 1999-12-09 | 2001-06-14 | Lexicon Genetics Incorporated | Human adam-ts proteases and polynucleotides encoding the same |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6391610B1 (en) * | 1999-08-06 | 2002-05-21 | The Cleveland Clinic Foundation | Nucleic acids encoding zinc metalloproteases |
EP1356028A2 (en) * | 2001-01-31 | 2003-10-29 | Incyte Genomics, Inc. | Protein modification and maintenance molecules |
-
2001
- 2001-02-14 IE IE20010121A patent/IE20010121A1/en not_active IP Right Cessation
- 2001-02-15 BE BE2001/0104A patent/BE1014089A4/fr not_active IP Right Cessation
- 2001-02-16 CA CA002332533A patent/CA2332533A1/en not_active Abandoned
- 2001-02-19 NL NL1017393A patent/NL1017393C2/nl not_active IP Right Cessation
-
2002
- 2002-12-23 NL NL1022252A patent/NL1022252C2/nl not_active IP Right Cessation
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999005291A2 (en) * | 1997-07-25 | 1999-02-04 | Du Pont Pharmaceuticals Company | Aggrecan degrading metallo proteases |
WO2001042468A1 (en) * | 1999-12-09 | 2001-06-14 | Lexicon Genetics Incorporated | Human adam-ts proteases and polynucleotides encoding the same |
Non-Patent Citations (1)
Title |
---|
HURSKAINEN TIINA L ET AL: "ADAM-TS5, ADAM-TS6, and ADAM-TS7, novel members of a new family of zinc metalloproteases: General features and genomic distribution of the Adam-TS family", JOURNAL OF BIOLOGICAL CHEMISTRY, AMERICAN SOCIETY OF BIOLOGICAL CHEMISTS, BALTIMORE, MD, US, vol. 274, no. 36, 3 September 1999 (1999-09-03), pages 25555 - 25563, XP002158991, ISSN: 0021-9258 * |
Also Published As
Publication number | Publication date |
---|---|
IE20010121A1 (en) | 2002-12-11 |
NL1017393C2 (nl) | 2003-01-09 |
NL1017393A1 (nl) | 2001-08-22 |
NL1022252A1 (nl) | 2003-01-23 |
CA2332533A1 (en) | 2001-08-18 |
NL1022252C2 (nl) | 2003-11-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Eipper et al. | Peptidylglycine α‐amidating monooxygenase: A multifunctional protein with catalytic, processing, and routing domains | |
Rodriguez et al. | Inducible degradation of IκBα in vitro and in vivo requires the acidic C-terminal domain of the protein | |
Gronewold et al. | The act operon controls the level and time of C‐signal production for Myxococcus xanthus development | |
Basilion et al. | The iron-responsive element-binding protein: localization of the RNA-binding site to the aconitase active-site cleft. | |
Kryukov et al. | Selenium metabolism in zebrafish: multiplicity of selenoprotein genes and expression of a protein containing 17 selenocysteine residues | |
RU2003112700A (ru) | Гены новых сериновых протеаз, родственных dppiv | |
WO1996039429A3 (en) | Serum protein produced exclusively in adipocytes | |
RU2218402C2 (ru) | Выделенный полипептид, имеющий гомологию относительно комплемент родственного белка адипоцитов (варианты), гибридный белок (варианты), экспрессирующий вектор, способ получения полипептида, поликлональное антитело, фрагмент выделенного полинуклеотида (варианты) | |
Chan et al. | Site-directed mutagenesis of human type X collagen: expression of α1 (X) NC1, NC2, and helical mutations in vitro and in transfected cells | |
Kato et al. | Unique expression patterns of matrix metalloproteinases in regenerating newt limbs | |
CA2290944A1 (en) | Pgc-1, a novel brown fat ppar.gamma. coactivator | |
Arsène et al. | Role of region C in regulation of the heat shock gene-specific sigma factor of Escherichia coli, ς32 | |
Szabova et al. | Expression pattern of four membrane‐type matrix metalloproteinases in the normal and diseased mouse mammary gland | |
Ulrich et al. | Expression profile of proteins involved in scar formation in the healing process of full‐thickness excisional wounds in the porcine model | |
JP4378409B2 (ja) | グリシン輸送体 | |
HK1091215A1 (en) | Method for screening inhibitors of the gamma-secretase | |
BE1014089A4 (fr) | Nouvelles metalloproteases possedant des domaines thrombospondine et compositions d'acides nucleiques les codant. | |
NO972313D0 (no) | Peptider som er i stand til å binde til GAP-protein-SH3-området, nukleotid-sekvenser som koder for dette samt fremstilling og bruk derav | |
KR950032622A (ko) | 전사 인자 에이피알에프(aprf) | |
Fleming et al. | Mapping of catalytically important residues in the rat L-histidine decarboxylase enzyme using bioinformatic and site-directed mutagenesis approaches | |
WO2002008280A3 (en) | SCREENING METHODS BASED ON SUPERACTIVATED αVβ3 INTEGRIN | |
JP2005525112A5 (nl) | ||
BR0112300A (pt) | Processo amplamente aplicável para a identificação de moduladores de receptores acoplados à proteìna g | |
Obara et al. | A novel domain of fibronectin revealed by epitope mapping of a monoclonal antibody which inhibits fibroblasts‐mediated collagen gel contraction | |
WO2003070768A3 (en) | Cd40 splice variants,method of detection thereof, compositions comprising said variant(s) or nucleic acid encoding the same and use thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RE | Patent lapsed |
Effective date: 20040228 |